RDY Historical Balance Sheet

RDY Stock  USD 13.99  0.31  2.17%   
Trend analysis of Dr Reddys Laboratories balance sheet accounts such as Retained Earnings of 279.2 B, Accounts Payable of 14.3 B, Cash of 13.6 B or Other Assets of 8.6 B provides information on Dr Reddys' total assets, liabilities, and equity, which is the actual value of Dr Reddys Laboratories to its prevalent stockholders. By breaking down trends over time using Dr Reddys balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Dr Reddys Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Dr Reddys Laboratories is a good buy for the upcoming year.

Dr Reddys Inventory

31.96 Billion

  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

About RDY Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Dr Reddys Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Dr Reddys Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Dr Reddys and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which RDY currently owns. An asset can also be divided into two categories, current and non-current.

Dr Reddys Balance Sheet Chart

At this time, Dr Reddys' Cash And Short Term Investments are fairly stable compared to the past year. Good Will is likely to rise to about 6.5 B in 2024, whereas Total Assets are likely to drop slightly above 214.9 B in 2024.

Total Current Liabilities

Total Current Liabilities is an item on Dr Reddys balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Dr Reddys Laboratories are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.
Most accounts from Dr Reddys' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Dr Reddys Laboratories current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
At this time, Dr Reddys' Cash And Short Term Investments are fairly stable compared to the past year. Good Will is likely to rise to about 6.5 B in 2024, whereas Total Assets are likely to drop slightly above 214.9 B in 2024.
 2021 2022 2023 2024 (projected)
Other Current Liabilities48.3B53.5B58.1B61.0B
Total Assets296.7B322.9B387.5B214.9B

Dr Reddys balance sheet Correlations

0.970.990.96-0.060.990.54-0.14-0.140.911.00.990.910.98-0.160.95-0.20.99-0.050.960.990.880.951.00.980.27
0.970.960.990.130.950.460.0-0.180.950.980.940.880.93-0.010.88-0.140.950.070.90.960.930.970.970.960.33
0.990.960.94-0.141.00.57-0.18-0.160.880.991.00.90.99-0.220.98-0.231.0-0.110.970.990.850.930.990.990.24
0.960.990.940.190.940.450.0-0.150.970.960.930.870.910.040.86-0.110.940.070.880.950.950.980.950.950.35
-0.060.13-0.140.19-0.15-0.360.680.090.21-0.03-0.170.04-0.220.87-0.310.52-0.140.7-0.27-0.070.220.13-0.08-0.120.41
0.990.951.00.94-0.150.56-0.23-0.130.890.991.00.90.99-0.240.98-0.251.0-0.160.980.990.870.930.990.990.23
0.540.460.570.45-0.360.56-0.45-0.310.50.510.590.320.6-0.490.63-0.40.57-0.380.490.520.360.540.560.570.43
-0.140.0-0.180.00.68-0.23-0.450.12-0.12-0.1-0.230.01-0.270.8-0.330.64-0.20.85-0.28-0.13-0.12-0.13-0.15-0.20.2
-0.14-0.18-0.16-0.150.09-0.13-0.310.12-0.24-0.15-0.130.19-0.160.4-0.110.59-0.130.07-0.06-0.08-0.26-0.24-0.18-0.150.1
0.910.950.880.970.210.890.5-0.12-0.240.910.880.770.87-0.010.81-0.20.89-0.010.810.890.980.990.910.910.34
1.00.980.990.96-0.030.990.51-0.1-0.150.910.980.90.97-0.140.94-0.210.99-0.010.950.990.880.950.990.980.26
0.990.941.00.93-0.171.00.59-0.23-0.130.880.980.891.0-0.260.99-0.261.0-0.160.980.990.840.920.990.990.24
0.910.880.90.870.040.90.320.010.190.770.90.890.860.080.860.150.90.030.90.940.750.80.890.880.31
0.980.930.990.91-0.220.990.6-0.27-0.160.870.971.00.86-0.310.99-0.30.99-0.210.980.980.840.920.980.990.23
-0.16-0.01-0.220.040.87-0.24-0.490.80.4-0.01-0.14-0.260.08-0.31-0.370.85-0.220.66-0.31-0.140.01-0.07-0.19-0.220.29
0.950.880.980.86-0.310.980.63-0.33-0.110.810.940.990.860.99-0.37-0.310.98-0.270.990.960.770.860.960.970.19
-0.2-0.14-0.23-0.110.52-0.25-0.40.640.59-0.2-0.21-0.260.15-0.30.85-0.31-0.230.39-0.26-0.15-0.19-0.24-0.23-0.240.24
0.990.951.00.94-0.141.00.57-0.2-0.130.890.991.00.90.99-0.220.98-0.23-0.140.980.990.860.930.990.990.25
-0.050.07-0.110.070.7-0.16-0.380.850.07-0.01-0.01-0.160.03-0.210.66-0.270.39-0.14-0.22-0.07-0.05-0.03-0.07-0.130.19
0.960.90.970.88-0.270.980.49-0.28-0.060.810.950.980.90.98-0.310.99-0.260.98-0.220.970.80.860.960.970.14
0.990.960.990.95-0.070.990.52-0.13-0.080.890.990.990.940.98-0.140.96-0.150.99-0.070.970.860.930.990.990.27
0.880.930.850.950.220.870.36-0.12-0.260.980.880.840.750.840.010.77-0.190.86-0.050.80.860.960.870.880.22
0.950.970.930.980.130.930.54-0.13-0.240.990.950.920.80.92-0.070.86-0.240.93-0.030.860.930.960.940.940.33
1.00.970.990.95-0.080.990.56-0.15-0.180.910.990.990.890.98-0.190.96-0.230.99-0.070.960.990.870.940.990.27
0.980.960.990.95-0.120.990.57-0.2-0.150.910.980.990.880.99-0.220.97-0.240.99-0.130.970.990.880.940.990.26
0.270.330.240.350.410.230.430.20.10.340.260.240.310.230.290.190.240.250.190.140.270.220.330.270.26
Click cells to compare fundamentals

Dr Reddys Account Relationship Matchups

Dr Reddys balance sheet Accounts

201920202021202220232024 (projected)
Total Assets232.2B265.5B296.7B322.9B387.5B214.9B
Other Current Liab39.4B45.3B48.3B53.5B58.1B61.0B
Total Current Liabilities72.8B81.5B97.8B85.7B96.0B69.8B
Total Stockholder Equity155.0B175.0B190.5B232.9B280.6B294.6B
Retained Earnings144.2B157.9B175.7B215.6B265.9B279.2B
Accounts Payable10.7B12.7B16.0B17.9B21.5B14.3B
Cash2.1B14.8B14.9B5.8B7.1B13.6B
Other Assets14.8B11.6B13.7B7.1B8.2B8.6B
Long Term Debt21.4B0.06.3B5.7B3.8B3.5B
Short Term Investments23.7B19.7B29.5B61.0B74.4B78.1B
Inventory35.1B45.4B50.9B48.7B63.6B32.0B
Total Liab77.3B90.5B106.1B90.0B107.0B89.6B
Intangible Assets27.7B35.6B27.2B30.7B37.0B24.7B
Property Plant Equipment52.3B57.1B62.2B66.3B76.2B80.1B
Short Long Term Debt Total22.1B30.3B33.8B13.5B20.0B19.0B
Other Liab3.5B3.1B2.7B2.5B2.9B3.1B
Property Plant And Equipment Net52.3B57.1B62.2B56.5B76.9B55.3B
Current Deferred Revenue1.9B2.0B2.6B2.0B1.4B1.4B
Net Debt20.0B15.5B19.0B7.7B12.9B12.3B
Non Current Assets Total101.9B117.2B115.5B118.6B139.5B98.4B
Non Currrent Assets Other2.6B952M948M12.7B16.1B16.9B
Cash And Short Term Investments25.7B34.6B44.4B66.7B81.5B85.5B
Net Receivables61.8B49.6B66.8B72.5B80.3B48.4B
Good Will4.0B4.6B4.4B5.5B4.3B6.5B
Common Stock Shares Outstanding166.1M166.3M166.3M166.4M166.7M175.5M
Liabilities And Stockholders Equity232.2B265.5B296.7B322.9B387.5B223.8B
Non Current Liabilities Total4.4B9.0B8.3B4.3B10.9B20.2B
Other Current Assets5.8B18.6B19.8B21.3B22.7B23.9B
Other Stockholder Equity7.5B8.2B8.4B10.3B1.7B1.6B
Total Current Assets130.4B148.2B181.1B204.3B248.0B127.1B
Accumulated Other Comprehensive Income2.4B1.3B1.1B1.3B4.0B3.8B
Short Term Debt20.8B24.0B28.1B12.2B14.0B27.0B
Property Plant And Equipment Gross52.3B57.1B142.0B152.3B170.1B161.6B
Net Tangible Assets91.9B123.3B134.8B158.9B182.7B102.9B
Long Term Investments3.1B8.3B8.0B6.1B5.3B4.6B
Short Long Term Debt20.3B24.0B28.1B12.2B12.7B16.6B
Long Term Debt Total1.3B6.3B5.7B1.3B1.2B1.1B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.